Viewing Study NCT03025360


Ignite Creation Date: 2025-12-25 @ 2:02 AM
Ignite Modification Date: 2026-02-26 @ 12:36 AM
Study NCT ID: NCT03025360
Status: APPROVED_FOR_MARKETING
Last Update Posted: 2019-12-19
First Post: 2017-01-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Expanded Access to Provide Larotrectinib for the Treatment of Cancers With a NTRK Gene Fusion
Sponsor: Bayer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module